MOLTIME
MRP: 1,990
Packaging: 10x1x1
Pack Type: tablet
Composition:
Ibandronic acid 150 mg tablets
Indication:
Treatment and Prevention of Postmenopausal Osteoporosis
Description:
Ibandronic Acid 150 mg is a bisphosphonate medication used primarily to prevent and treat osteoporosis in postmenopausal women. It helps strengthen bones by slowing down bone loss and reducing the risk of fractures. It is also prescribed to patients with bone metastases or certain bone diseases.
Tags:
- Increases bone density and strength
- Reduces risk of vertebral and non-vertebral fractures
- Convenient once-monthly dosage
- Supports treatment of osteoporosis and bone metastases
Usage Information
Dosage
Take one 150 mg tablet orally once a month, at least 60 minutes before the first food, drink, or other medication of the day. Swallow the tablet whole with a full glass of plain water. Remain upright (sitting or standing) for at least 60 minutes after taking the tablet.
Side Effects
Heartburn or acid reflux Nausea or stomach pain Muscle or joint pain Rare: jaw bone problems (osteonecrosis)
Contraindications
Hypersensitivity to ibandronic acid or bisphosphonates Abnormalities of the esophagus that delay emptying Inability to sit or stand upright for at least 60 minutes Severe kidney impairment Hypocalcemia (low blood calcium)
Availability
Ibandronic acid 150 mg tablets Osteoporosis treatment tablets Bone loss medication Bisphosphonate tablets Ibandronate sodium